During the past decade, China Medical University Hospital conducted 466 clinical trials. In the 10-year time frame, 466 clinical trials started and 154 clinical trials were completed, i.e. on average, 33% percent of trials that started reached the finish line to date. In the past 5 years, 242 clinical trials started and 112 clinical trials were completed. i.e. 46.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "China Medical University Hospital" #1 sponsor was "China Medical University Hospital" with 154 trials, followed by "Janssen Research & Development, LLC" with 35 trials sponsored, "Pfizer" with 32 trials sponsored, "Eli Lilly and Company" with 25 trials sponsored and "Hoffmann-La Roche" with 25 trials sponsored. Other sponsors include 356 different institutions and companies that sponsored additional 183 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "China Medical University Hospital" #1 collaborator was "China Medical University Hospital" with 26 trials as a collaborator, "National Cheng-Kung University Hospital" with 16 trials as a collaborator, "Chang Gung Memorial Hospital" with 15 trials as a collaborator, "National Taiwan University Hospital" with 15 trials as a collaborator and "Taipei Veterans General Hospital, Taiwan" with 14 trials as a collaborator. Other collaborators include 260 different institutions and companies that were collaborators in the rest 148 trials.

According to Clinical.Site data, the most researched conditions in "China Medical University Hospital" are "Breast Cancer" (14 trials), "Multiple Myeloma" (11 trials), "Gastric Cancer" (10 trials), "Stroke" (10 trials) and "Carcinoma, Non-Small-Cell Lung" (9 trials). Many other conditions were trialed in "China Medical University Hospital" in a lesser frequency.

Most popular intervention types in "China Medical University Hospital" are "Drug" (427 trials), "Other" (75 trials), "Biological" (55 trials), "Device" (43 trials) and "Procedure" (26 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (135 trials), "Cisplatin" (20 trials), "Carboplatin" (17 trials), "Paclitaxel" (16 trials) and "Pembrolizumab" (15 trials). Other intervention names were less common.

The vast majority of trials in "China Medical University Hospital" are 590 trials for "All" genders, 19 trials for "Female" genders and 19 trials for "Male" genders.

Currently, there are 228 active trials in "China Medical University Hospital". 4 are not yet recruiting, 130 are recruiting, 90 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 248 completed trials in China Medical University Hospital, undefined suspended trials, and 50 terminated clinical trials to date.

Out of the total trials that were conducted in China Medical University Hospital, 56 "Phase 1" clinical trials were conducted, 150 "Phase 2" clinical trials and 244 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 31 trials, and there were also 102 trials that are defined as “Not Applicable".